Key result
Roux-en-Y gastric bypass and sleeve gastrectomy resulted in similar improvements in insulin sensitivity and β-cell function in nondiabetic obese patients after ~20% weight loss.
Why the study?
Does Roux-en-Y gastric bypass compared to sleeve gastrectomy result in different improvements in insulin sensitivity and β-cell function in nondiabetic insulin-resistant obese patients?
Cohort (n=14)
Does Roux-en-Y gastric bypass compared to sleeve gastrectomy result in different improvements in insulin sensitivity and β-cell function in nondiabetic insulin-resistant obese patients?
Matched weight loss (~20%) induced by either Roux-en-Y gastric bypass or sleeve gastrectomy results in similar improvements in insulin sensitivity and β-cell function in obese nondiabetic patients.
Similar benefits after matched weight loss do not favor one procedure; leaves open need for randomized confirmation in insulin-resistant patients.
OBJECTIVE: The effects of marked weight loss, induced by Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) surgeries, on insulin sensitivity, β-cell function and the metabolic response to a mixed meal were evaluated. METHODS: Fourteen nondiabetic insulin-resistant patients who were scheduled to undergo SG (n = 7) or RYGB (n = 7) procedures completed a hyperinsulinemic-euglycemic clamp procedure and a mixed-meal tolerance test before surgery and after losing ∼20% of their initial body weight. RESULTS: Insulin sensitivity (insulin-stimulated glucose disposal during a clamp procedure), oral glucose tolerance (postprandial plasma glucose area under the curve), and β-cell function (insulin secretion in relationship to insulin sensitivity) improved after weight loss, and were not different between surgical groups. The metabolic response to meal ingestion was similar after RYGB or SG, manifested by rapid delivery of ingested glucose into the systemic circulation and a large early postprandial increase in plasma glucose, insulin, and C-peptide concentrations in both groups. CONCLUSIONS: When matched on weight loss, RYGB and SG surgeries result in similar improvements in the two major factors involved in regulating plasma glucose homeostasis, insulin sensitivity and β-cell function in obese people without diabetes.
No takes yet. Share an insight, caveat, or question.
Bradley et al. (2014) conducted a cohort in Obesity with insulin resistance (n=14). Roux-en-Y gastric bypass (RYGB) vs. Sleeve gastrectomy (SG) was evaluated on Insulin sensitivity, β-cell function, and metabolic response to a mixed meal. Roux-en-Y gastric bypass and sleeve gastrectomy resulted in similar improvements in insulin sensitivity and β-cell function in nondiabetic obese patients after ~20% weight loss.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: